Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Bristol-myers squibb company    save search

Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab)
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 1.04% H: 1.39% C: -0.28%

opdivo trial plus
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab)
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

drug opdivo review food application
Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC™ Platform Technology
Published: 2023-11-28 (Crawled : 20:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.55% C: -0.27%
RNA | $8.04 1.39% 1.37% 850K twitter stocktwits trandingview |
Health Technology
| | O: 25.32% H: 3.63% C: -8.29%

expansion collaboration technology cardiovascular platform
Locally Advanced Pancreatic Cancer Market Report 2023-2028: Recent Advancements in Immunotherapy Inject New Hope into LAPC Market
Published: 2023-11-21 (Crawled : 23:00) - prnewswire.com
AZNCF | $125.75 8.15% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: -0.05%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 1.53% C: 1.37%
AZN | $63.5 -0.14% -0.14% 6.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.89% H: 0.33% C: -0.16%

report hope cancer pancreatic immunotherapy market
Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma
Published: 2023-11-20 (Crawled : 13:00) - biospace.com/
TSVT | $2.65 12.77% 11.32% 2.1M twitter stocktwits trandingview |
| | O: -12.96% H: 1.06% C: -7.45%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -4.69% H: 2.85% C: 0.25%

fda review update therapy
FDA Roundup: November 17, 2023
Published: 2023-11-17 (Crawled : 22:00) - prnewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

fda
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $155.4 -0.78% -0.02% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.0% C: 0.0%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.0% C: 0.0%
GILD | $78.03 -1.68% -1.7% 8.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.0% C: 0.0%

reach research hiv market
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published: 2023-11-10 (Crawled : 15:00) - prnewswire.com
PFE A | $28.63 -0.56% 0.0% 35M twitter stocktwits trandingview |
Health Technology
| | O: -4.83% H: 0.0% C: 0.0%
JNJ | News | $155.4 -0.78% -0.02% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 0.0% C: 0.0%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -3.68% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.0% C: 0.0%
AZN | $63.5 -0.14% -0.14% 6.2M twitter stocktwits trandingview |
Health Technology
| | O: -2.88% H: 0.0% C: 0.0%

report research market
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published: 2023-11-10 (Crawled : 12:30) - prnewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -3.68% H: 0.0% C: 0.0%
MRTX | $56.64 -0.02% -0.02% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.0% C: 0.0%

krasg12 lung chmp positive cancer cell treatment therapeutics
Tempus Announces Research Collaboration with Bristol Myers Squibb to Apply Multimodal AI Approaches
Published: 2023-11-08 (Crawled : 20:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 0.11% C: -0.19%

research collaboration
HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS
Published: 2023-11-08 (Crawled : 13:00) - prnewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 0.11% C: -0.19%
STIM | $1.8 -4.76% -5.0% 55K twitter stocktwits trandingview |
Health Technology
| | O: 5.11% H: 0.0% C: 0.0%
HRMY | News | $31.07 -3.09% -3.19% 780K twitter stocktwits trandingview |
Health Technology
| | O: -2.78% H: 0.59% C: -1.72%


Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Published: 2023-11-06 (Crawled : 15:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 3.16% H: 0.77% C: -0.66%
MRTX | $56.64 -0.02% -0.02% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.59% C: 0.27%

therapeutics financial results
Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors
Published: 2023-11-06 (Crawled : 13:00) - globenewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 3.16% H: 0.77% C: -0.66%

al102 drug tumors pharmaceuticals designation
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -1.84% H: 1.08% C: 0.61%
MRTX | $56.64 -0.02% -0.02% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 0.43% C: -0.38%
KURA | $11.27 1.81% 1.77% 800K twitter stocktwits trandingview |
Health Technology
| | O: -4.76% H: 6.0% C: 5.25%

ko-2806 collaboration therapeutics agreement
Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 0.0% C: 0.0%


AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 0.0% C: 0.0%
XNCR | $20.2 4.88% 4.65% 500K twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 2.61% H: 0.0% C: 0.0%
REGN | News | $849.57 1.65% 1.63% 560K twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%
BGNE J | $182.01 -1.16% -1.18% 180K twitter stocktwits trandingview |
Health Technology
| | O: 1.38% H: 0.0% C: 0.0%
AMGN S | $271.33 0.74% 0.73% 2M twitter stocktwits trandingview |
Health Technology
| | O: -3.22% H: 0.0% C: 0.0%

financial results
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Published: 2023-10-31 (Crawled : 06:00) - biospace.com/
MS | News 0 d | $80.35 1.18% -0.03% 5.3M twitter stocktwits trandingview |
Finance
| | O: 0.83% H: 0.0% C: 0.0%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 0.0% C: 0.0%
MRTX | $56.64 -0.02% -0.02% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: 0.0%


Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD™ Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 0.0% C: 0.0%
KPTI | $0.8353 -1.83% -1.87% 750K twitter stocktwits trandingview |
Health Technology
| | O: 2.92% H: 6.08% C: -3.35%

collaboration trial
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
XYF | News 0 d | $3.76 1.62% 2.39% 18K twitter stocktwits trandingview |
Finance
| | O: 2.29% H: 4.87% C: 4.87%
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -4.68% H: 2.46% C: -1.83%
MRTX | $56.64 -0.02% -0.02% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.47% C: 0.2%

financial results
Global HIV Diagnostics Market Predicted to Reach $1.5 Billion by 2030, with a CAGR of 5.5%
Published: 2023-10-25 (Crawled : 18:00) - prnewswire.com
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 1.34% C: 1.05%
GILD | $78.03 -1.68% -1.7% 8.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.89% C: 0.62%

reach global hiv diagnostics market
Gainers vs Losers
69% 31%

Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M twitter stocktwits trandingview |
Health Technology

SVFD | News | $3.09 43.72% 30.42% 64M twitter stocktwits trandingview |

FTEL | $2.04 43.66% 30.39% 110K twitter stocktwits trandingview |

HPCO 4 | $0.4824 41.92% 29.54% 28M twitter stocktwits trandingview |

ALGS | News | $0.6475 -5.06% 26.67% 2.1M twitter stocktwits trandingview |
Health Technology

GTHX | $3.16 30.58% 23.42% 10M twitter stocktwits trandingview |
Health Technology

KEQU | $22.5 27.62% 21.64% 24K twitter stocktwits trandingview |
Producer Manufacturing

GSIT | $3.09 27.16% 21.36% 2.2M twitter stocktwits trandingview |
Electronic Technology

SSKN P | $0.628 25.6% 20.38% 210K twitter stocktwits trandingview |
Health Technology

GLUE | $3.66 22.82% 18.58% 510K twitter stocktwits trandingview |
Professional, Scientific, and T...


Your saved searches
Save your searches and get alerts when important news are released.